Pembrolizumab with or without platinum-based chemotherapy as first-line treatment in advanced NSCLC expressing PD-L1 ≥50%: The PERSEE randomized phase III trial (GFPC 01-2020)

Annals of Vascular Surgery · Elsevier

Аннотация

Publication date: Available online 25 October 2026 Source: Annals of Oncology Author(s): Renaud Descourt, Alice Mogenet, Maelys Consigny, Marie Bernardi, Romain Corre, Olivier Bylicki, Jean-Bernard Auliac, Alain Vergnenègre, Charles Ricordel, Julian Pinsolle, Marie Wislez, Maud Pedrono, Rémi Veillon, Lionel Falchero, Florian Guisier, Pierre-Alexandre Hauss, Acya Bizieux-Thaminy, Stéphane Hominal, Anne Madroszyk, Hubert Curcio

Читать у издателя →

Похожие статьи